Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Aditxt, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −2 vs. Q4 2024
- Shares held
- 57.5K
- −19.1K (−24.9%) vs. Q4 2024
- Total value
- $213.3K
- +$199.5K (+1,436.1%) vs. Q4 2024
- New holders
- 1
- 3 more added
- Sold out
- 3
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 9 | $19.8K |
| Q4 2025 | 14 | $48.4K |
| Q3 2025 | 14 | $35.9K |
| Q2 2025 | 13 | $50.5K |
| Q1 2025 | 9 | $213.3K |
| Q4 2024 | 11 | $13.9K |
| Q3 2024 | 13 | $29.7K |
| Q2 2024 | 8 | $23.4K |
| Q1 2024 | 10 | $62.2K |
| Q4 2023 | 11 | $31.2K |
| Q3 2023 | 12 | $826.4K |
| Q2 2023 | 14 | $313.8K |
| Q1 2023 | 15 | $618.3K |
| Q4 2022 | 16 | $805.6K |
| Q3 2022 | 16 | $983.2K |
| Q2 2022 | 28 | $392.5K |
| Q1 2022 | 23 | $1.14M |
| Q4 2021 | 27 | $2.01M |
| Q3 2021 | 25 | $2.48M |
| Q2 2021 | 18 | $1.62M |
| Q1 2021 | 22 | $1.63M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Aditxt, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 27,796 | $124.7K | 0.00% | +26,295+1,751.8% | Added |
| HRT Financial LP | 13,609 | $61.0K | 0.00% | −47,783−77.8% | Reduced |
| Tower Research Capital LLC (TRC) | 3,916 | $17.6K | 0.00% | +3,670+1,491.9% | Added |
| Morgan Stanley | 2,074 | $9.30K | 0.00% | +2,074 | New |
| SBI Securities Co., Ltd. | 92 | $413 | 0.00% | −1,909−95.4% | Reduced |
| IFP Advisors, Inc | 10,054 | $380 | 0.00% | +10,039+66,926.7% | Added |
| Bank of America Corp | 3 | $13 | 0.00% | −68−95.8% | Reduced |
| Group One Trading, L.P. | 3 | $13 | 0.00% | −13−81.3% | Reduced |
| Darwin Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,354−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |